These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 1576621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
    Cornick NA, Cuchural GJ, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM.
    J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
    Fernández Canigia L, Castello L, Di Martino A, Greco G, Legaria MC, Litterio M, Predari SC, Rollet R, Rossetti A, Carloni G, Sarchi MI, Bianchini H.
    Rev Argent Microbiol; 2007 Jun; 39(3):156-60. PubMed ID: 17987852
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW, Weeks LS, Aldridge KE.
    Diagn Microbiol Infect Dis; 1992 Jun; 15(4):321-30. PubMed ID: 1611847
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.
    J Hyg Epidemiol Microbiol Immunol; 1991 Jun; 35(2):189-97. PubMed ID: 1940333
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic sensitivity of the Bacteroides fragilis group in Denmark. Danish Study Group.
    Bremmelgaard A, Jansen JE, Justesen T, Gottschau A.
    APMIS; 1993 Sep; 101(9):727-31. PubMed ID: 8240792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
    Rokosz A, Pawłowska J, Sawicka-Grzelak A, Luczak M.
    Med Dosw Mikrobiol; 2004 Sep; 56(3):245-53. PubMed ID: 15773501
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey.
    Behra-Miellet J, Calvet L, Mory F, Muller C, Chomarat M, Bézian MC, Bland S, Juvenin ME, Fosse T, Goldstein F, Jaulhac B, Dubreuil L.
    Anaerobe; 2003 Jun; 9(3):105-11. PubMed ID: 16887696
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
    Betriu C, Sánchez A, Gómez M, Palau ML, Picazo JJ.
    J Antimicrob Chemother; 1999 Jan; 43(1):133-6. PubMed ID: 10381111
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.